REDEFINE 1 (Garvey et al., NEJM 2025) is the only Phase 3 trial of an amylin + incretin co-administered combination, pairing cagrilintide 2.4 mg with semaglutide 2.4 mg
There have been no large-scale, long-term studies to truly evaluate safety especially not for cancer risk
The arm may feel weak with attempts to bend the elbow or when twisting the forearm into supination (palm up)
Warden et al., Low-intensity pulsed ultrasound for chronic patellar tendinopathy: a randomized, double-blind, placebo-controlled trial, Rheumatology (Oxford, England) 47, no
These syringes are marked in units (where 100 units equals 1ml), which aligns perfectly with the concentration math above
Though much of the research around PDA and BPC-157 remains preliminary, studies and clinical observations suggest the following mechanisms: 1